Dublin, Nov. 16, 2020 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization 2021 - 2025" report has been added to ResearchAndMarkets.com's offering.
How will COVID-19 affect Syndromic and Infectious Disease Diagnostics? The COVID pandemic is ushering in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.
Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician's Office or even the Home?
Syndromic testing is proving itself in the market. Players are reporting double-digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti-Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.
The report forecasts the market size out to 2024. In a special section the report looks at the numbers on how syndromic molecular diagnostics is replacing traditional panel-based ordering of infectious disease tests.
Key Topics Covered:
1. Introduction and Market Definition
2. The Infectious Diseases - Guide to the Pathogens
3. Industry Overview
4. Market Trends
5. Syndromic Testing Recent Developments
6. The Global Market for Syndromic Multiplex Diagnostics
7. Global Syndromic Multiplex Markets - By Syndrome
8. Global MDx Infectious Disease Markets - by Place
Companies Mentioned
- Abbott Diagnostics (Alere)
- Accelerate Diagnostics
- Ador Diagnostics
- Akkoni Biosystems
- Alveo Technologies
- Applied BioCode
- Atlas Genetics
- Aus Diagnostics
- BD Diagnostics
- Bio-Rad Laboratories
- Biocartis
- BioFire Diagnostics
- bioMerieux
- Bosch Healthcare Solutions GmbH
- Cepheid
- Cue Health
- Curetis
- Diagenode Diagnostics
- Diasorin
- Expedeon
- Fusion Genomics
- GenePOC Diagnostics
- Genetic Signatures
- GenMark Dx
- Hologic
- Immunexpress
- Inflammatix
- Invetech
- Janssen Diagnostics
- Karius
- Lexigene
- Luminex
- Mbio Diagnostics
- Meridian Bioscience
- Mesa Biotech
- Mobidiag
- Nanomix
- Novacyt
- Oxford Nanopore
- Panagene
- Primerdesign
- Prominex
- Qiagen (Statdx)
- Quantumdx
- Quidel
- Roche Molecular Diagnostics
- Saw Diagnostics
- Seegene
- Sensovation
- Siemens Healthineers (Fast Track Diagnostics)
- SkylineDx
- Sona Nanotech
- SpeeDx
- T2 Biosystems
- Thermo Fisher
- Veramarx
- XCR Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/2hw9p7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
"traditional" - Google News
November 16, 2020 at 06:28PM
https://ift.tt/3kHDz04
How Syndromic Molecular Diagnostics is Replacing Traditional Panel-Based Ordering of Infectious Disease Tests - GlobeNewswire
"traditional" - Google News
https://ift.tt/36u1SIt
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "How Syndromic Molecular Diagnostics is Replacing Traditional Panel-Based Ordering of Infectious Disease Tests - GlobeNewswire"
Post a Comment